Matthew E. Korenberg, President & COO: Ligand Pharmaceuticals LGND Sell · Filed 24/09/24

Trade details

Type: Insider sale
Amount: $653,227.5
Shares · price: 6,275 sh · $104.10 a share
Held after: 50,777 sh
Stock: Ligand Pharmaceuticals LGND
Person: Matthew E. KorenbergPresident & COO
Trade date: 24/09/20
Filed: 24/09/24
Days to filing: 4 days

Sold 11.0% of holdings

Share of holding sold: 11.0%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/21~24/10/20

Matthew E. Korenberg's recent trades

Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$720.4K
7,090 sh
$720.4K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$248.2K
2,481 sh
$248.2K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$20.5K
201 sh
$20.5K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$648.7K
6,177 sh
$648.7K
Filed 24/08/26
Traded 24/08/26
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$554.1K
5,212 sh
$554.1K
Filed 24/08/26
Traded 24/08/26